What is Helius Medical Technologies Earnings Yield (Joel Greenblatt) %?
Helius Medical Technologies's Enterprise Value for the quarter that ended in Mar. 2024 was $1.58 Mil.
Helius Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-11.88 Mil. Helius Medical Technologies's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2024 was -769.23%.
The historical rank and industry rank for Helius Medical Technologies's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
HSDT'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -14053.25 Med: -61.05 Max: 24515.2
Current: -10000
During the past 10 years, the highest Earnings Yield (Joel Greenblatt) of Helius Medical Technologies was 24515.20%. The lowest was -14053.25%. And the median was -61.05%.
HSDT's Earnings Yield (Joel Greenblatt) % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.16
vs HSDT: -10000.00
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Helius Medical Technologies's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Helius Medical Technologies Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for Helius Medical Technologies's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Helius Medical Technologies Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of Helius Medical Technologies's Earnings Yield (Joel Greenblatt) %
For the Medical Devices subindustry, Helius Medical Technologies's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Helius Medical Technologies's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Helius Medical Technologies's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Helius Medical Technologies's Earnings Yield (Joel Greenblatt) % falls into.
Helius Medical Technologies Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Helius Medical Technologiess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as
Helius Medical Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.88 Mil.
Helius Medical Technologies (NAS:HSDT) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Helius Medical Technologies Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Helius Medical Technologies's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Helius Medical Technologies (Helius Medical Technologies) Business Description
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, non-implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HSDT has been successfully added to your 